Fairmount Funds Management’s Korsana Biosciences KRSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KRSA
Fairmount Funds Management's KRSA Position: Q3 2026 in Review
Fairmount Funds Management opened a new position in Korsana Biosciences (KRSA) in Q3 2026: 9,103,729 shares worth $291M. The stake represents 18.27% of the portfolio and ranks #2 among its holdings.
44 funds tracked by Wall St. Rank hold KRSA as of Q3 2026.
- Fairmount Funds Management held 9,103,729 shares of Korsana Biosciences worth $291M as of Q3 2026.
- Korsana Biosciences was a new Fairmount Funds Management position in Q3 2026.
- Korsana Biosciences made up 18.27% of Fairmount Funds Management's portfolio in Q3 2026, its #2 holding.
- 44 funds tracked by Wall St. Rank held Korsana Biosciences as of Q3 2026.
Based on Fairmount Funds Management's 13F filing for Q3 2026, filed 16 Nov 2026.